WallStreetZenWallStreetZen

NASDAQ: SNYR
Synergy Chc Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SNYR

Based on 1 analyst offering 12 month price targets for Synergy Chc Corp

Min Forecast
$3.75+1,813.27%
Avg Forecast
$3.75+1,813.27%
Max Forecast
$3.75+1,813.27%

Should I buy or sell SNYR stock?

Based on 1 analyst offering ratings for Synergy Chc Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SNYR stock forecasts and price targets.

SNYR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-10

1 of 1

Forecast return on equity

Is SNYR forecast to generate an efficient return?

Company
-30.21%
Industry
-104.81%
Market
135.76%
SNYR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SNYR forecast to generate an efficient return on assets?

Company
118.78%
Industry
5.64%
SNYR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SNYR earnings per share forecast

What is SNYR's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.22
Avg 2 year Forecast
$0.52

SNYR revenue forecast

What is SNYR's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$44.8M+61.84%
Avg 2 year Forecast
$49.8M+79.78%
SNYR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SNYR revenue growth forecast

How is SNYR forecast to perform vs Medical Distribution companies and vs the US market?

Company
61.84%
Industry
5.38%
Market
23.07%
SNYR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SNYR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SNYR vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
SNYR$0.20$3.75+1,813.27%Buy
COSM$0.21N/AN/A
FOCL$4.72$10.00+111.86%Buy
ACH$3.33$4.56+37.03%Buy
AHG$1.34N/AN/A
View Top Medical Distribution Stocks

Synergy Chc Stock Forecast FAQ

Is Synergy Chc Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SNYR) stock is to Buy SNYR stock.

Out of 1 analyst, 0 (0%) are recommending SNYR as a Strong Buy, 1 (100%) are recommending SNYR as a Buy, 0 (0%) are recommending SNYR as a Hold, 0 (0%) are recommending SNYR as a Sell, and 0 (0%) are recommending SNYR as a Strong Sell.

If you're new to stock investing, here's how to buy Synergy Chc stock.

What is SNYR's earnings growth forecast for 2026-2027?

(NASDAQ: SNYR) Synergy Chc's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 35.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,344.48%.

Synergy Chc's earnings in 2026 is -$15,786,370.On average, 4 Wall Street analysts forecast SNYR's earnings for 2026 to be $3,343,534, with the lowest SNYR earnings forecast at $1,898,245, and the highest SNYR earnings forecast at $4,849,912.

In 2027, SNYR is forecast to generate $7,674,930 in earnings, with the lowest earnings forecast at $3,504,452 and the highest earnings forecast at $12,046,555.

What is SNYR's revenue growth forecast for 2026-2027?

(NASDAQ: SNYR) Synergy Chc's forecast annual revenue growth rate of 61.84% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 5.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.07%.

Synergy Chc's revenue in 2026 is $27,702,980.On average, 4 Wall Street analysts forecast SNYR's revenue for 2026 to be $668,036,254, with the lowest SNYR revenue forecast at $491,636,539, and the highest SNYR revenue forecast at $848,607,936.

In 2027, SNYR is forecast to generate $742,088,673 in revenue, with the lowest revenue forecast at $540,791,253 and the highest revenue forecast at $948,392,453.

What is SNYR's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SNYR) forecast ROA is 118.78%, which is higher than the forecast US Medical Distribution industry average of 5.64%.

What is SNYR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SNYR price target, the average SNYR price target is $3.75, with the highest SNYR stock price forecast at $3.75 and the lowest SNYR stock price forecast at $3.75.

The Wall Street analyst predicted that Synergy Chc's share price could reach $3.75 by Jun 10, 2027. The average Synergy Chc stock price prediction forecasts a potential upside of 1,813.27% from the current SNYR share price of $0.20.

What is SNYR's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: SNYR) Synergy Chc's current Earnings Per Share (EPS) is -$1.59. On average, analysts forecast that SNYR's EPS will be $0.22 for 2026, with the lowest EPS forecast at $0.13, and the highest EPS forecast at $0.33. In 2027, SNYR's EPS is forecast to hit $0.52 (min: $0.24, max: $0.81).

What is SNYR's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SNYR) forecast ROE is -30.21%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.